BEIJING -- Researchers from the Institute of Automation at the Chinese Academy of Sciences have revealed the intrinsic ...

D Molecular Therapeutics is undervalued, with its lead candidate 4D-150 showing potential. Click here to find out why I rate ...

Biogen Inc. (NASDAQ:BIIB) and Stoke Therapeutics, Inc. (NASDAQ:STOK) collaborated to develop and commercialize zorevunersen ...

The mucopolysaccharidosis market is witnessing a surge in innovation, driven by cutting-edge gene therapies, enzyme replacement treatments, and novel drug developments. The market is poised for ...

The high cost of sickle cell gene therapies is pushing private insurers and Medicaid programs to develop new payment models.

Solid said that the first patients to receive its Duchenne gene therapy all produced high levels of the target protein, an ...

An Italian foundation that helped a young boy overcome Wiskott-Aldrich syndrome becomes the first non-profit in the world to ...

Vincent Gaynor remembers, almost to the minute, when he realized his part in birthing the breakthrough gene therapy Zolgensma ...

In today's Daily Briefing, we tell you how city leaders hope to expand the local economy, how blowing sand is being addressed ...

You may have heard about the large underground seed vault in Svalbard, Norway, which opened in 2008. But you might be ...

CFO Beth Jantzen reported total revenues of $1.2 million for Q1 2025, a year-over-year increase driven by higher product revenue from DNA Tagging and increased isotopic testing services. Operating ...

Voters will choose between Decker and Schwab when they cast their ballots in the Feb. 25 Democratic primary to determine not only their party’s nominee but the city’s treasurer.